🇺🇸 FDA
Patent

US 9149489

Inhibitors of glycolysis useful in the treatment of brain tumors

granted A61KA61K31/70

Quick answer

US patent 9149489 (Inhibitors of glycolysis useful in the treatment of brain tumors) held by The Board of Regents of the University of Texas System expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K31/70